Speaker Name: Oyedotun Babajide
Category: (Speaker/Oral Presentation)
Location: US
Research interest: Pancreatology
Babajide O1, Ogbon E O2, Adelodun A3, Agbalajobi O4, Ogunsesan Y5 , 1(1545 Atlantic Avenue, Brooklyn NY, USA, Interfaith Medical Center, NY, USA), 2(1 Hurley Plaza, Flint, MI, USA, Hur-ley Medical Center, Flint, USA), 3(506 Lenox Ave, New York, NY, USA, Harlem Hospital Center, NY, USA), 4(200 Meyran Ave # 318, Pittsburgh, PA,USA, olufunsoa@gmail.com, University of Pittsburgh Medical Center, Pittsburgh, USA), 5(4301 W Markham St, Little Rock, AR, USA, University of Arkansas for Medical Sciences, Little Rock, USA)
Biography: Oyedotun Babajide, MD completed his medical degree from the University of Ibadan, Nigeria. He is currently undergoing his residency in internal medicine at the Interfaith Medical Center, New York.
Global Journal of Gastroenterology & Hepatology Research [GJGHR]
Introduction: The global pandemic of Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection causes respiratory symptoms and notably also affects the gastrointestinal system.
Methods: A systematic review of the available literature on the topic was performed with a search key using the terms “SARS COV 2”, “Pancreatitis”, “COVID-19” and synonyms. The search was conducted on December 27th 2020 using PUBMED, EMBASE, CENTRAL, Web of Science, and Scopus. A meta-analysis was not conducted due to the poor comparability of the studies.
Results: We reviewed 66 studies that reported data on patients with polymerase chain reaction (PCR)-confirmed SARS-CoV-2 infection and AP using the Atlanta Criteria. Our evaluation revealed a wide age range and diverse clinical presentation of COVID-19 with or without symptoms of AP, some of which preceded typical COVID-19 symptoms. We observed a myriad of complications and one study revealed that patients with both conditions were more likely to require mechanical ventilation and had longer lengths of hospital stay compared to patients with AP without COVID-19. Treatment for AP was mostly supportive, with varied therapies employed for COVID-19. Most cases were considered idiopathic and presumed to be SARS-CoV-2-induced as established etiological factors were not reported.
Conclusion: AP should be considered in COVID-19 patients, especially in those exhibiting gastrointestinal symptoms. Evidence to establish a causal relationship between SARS-CoV-2 infection and AP is currently lacking.
Keywords: COVID-19, SARS COV 2, Acute Pancreatitis, Pneumonia, Abdominal pain
Tags
Crohn’s and Colitis Journals | Gastroenterology & Hepatology Journals | Gastroenterology Journals | Research Gastroenterology and Hepatology Journals | Clinical and Experimental Gastroenterology Journals | Gastrointestinal Endoscopy Journals | Therapeutic Advances in Gastroenterology Journals | Colorectal Disease: clinical and molecular gastroenterology and surgery Journals | Inflammatory Bowel Diseases Journals | Expert Review of Gastroenterology & Hepatology Journals | Clinical Colorectal Journals | Cancer Gut Journals | Endoscopy Journals | Hepatitis B Annual Journals | Hepato-biliary-Pancreatic Sciences Journals | Medical Bulletin Journals
Upcoming Conference:
World Gastroenterology, IBD, Hepatology Conference & Exhibition
Visit here: https://gastroenterology.utilitarianconferences.com/
Submit your abstract/research paper here: https://gastroenterology.utilitarianconferences.com/submit-abstract
Attend as a Speaker/Poster/Delegate In-person kindly register here: https://gastroenterology.utilitarianconferences.com/registration
Attend as a Speaker/Poster/Delegate virtually kindly register: https://gastroenterology.utilitarianconferences.com/virtual-registration